PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28679088
OWN - NLM
STAT- MEDLINE
DA  - 20170705
DCOM- 20170711
LR  - 20170713
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 1
DP  - 2017 Jul 06
TI  - Drug Combinations with Transplantation for Myeloma.
PG  - 93-94
LID - 10.1056/NEJMc1705671 [doi]
FAU - Attal, Michel
AU  - Attal M
AD  - Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
      [email protected]
FAU - Richardson, Paul G
AU  - Richardson PG
AD  - Dana-Farber Cancer Institute, Boston, MA.
FAU - Moreau, Philippe
AU  - Moreau P
AD  - Centre Hospitalier Universitaire de Nantes-Hotel Dieu, Nantes, France.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Drug Combinations)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Jul 6;377(1):91-2. PMID: 28679086
CON - N Engl J Med. 2017 Jul 6;377(1):92. PMID: 28679087
CON - N Engl J Med. ;377(1):92-3. PMID: 28691787
MH  - Antineoplastic Combined Chemotherapy Protocols
MH  - Drug Combinations
MH  - *Hematopoietic Stem Cell Transplantation
MH  - Humans
MH  - *Multiple Myeloma
MH  - Transplantation, Autologous
EDAT- 2017/07/06 06:00
MHDA- 2017/07/14 06:00
CRDT- 2017/07/06 06:00
AID - 10.1056/NEJMc1705671#SA4 [pii]
AID - 10.1056/NEJMc1705671 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Jul 6;377(1):93-94. doi: 10.1056/NEJMc1705671.